These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 20435321)

  • 41. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ
    J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.
    Saidi A; Selzman CH; Ahmadjee A; Al-Sarie M; Snow GL; Wever-Pinzon O; Alharethi R; Reid B; Stehlik J; Kfoury AG; Bader F
    ASAIO J; 2018; 64(1):38-42. PubMed ID: 28661912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support.
    Klotz S; Deng MC; Stypmann J; Roetker J; Wilhelm MJ; Hammel D; Scheld HH; Schmid C
    Ann Thorac Surg; 2004 Jan; 77(1):143-9; discussion 149-50. PubMed ID: 14726050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Left Heart Catheterization Ramp Protocol to Guide Hemodynamic Optimization in Patients Supported With Left Ventricular Assist Device Therapy.
    Rosenbaum AN; Frantz RP; Kushwaha SS; Stulak JM; Maltais S; Behfar A
    J Am Heart Assoc; 2019 Feb; 8(4):e010232. PubMed ID: 30755070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.
    Etz CD; Welp HA; Tjan TD; Hoffmeier A; Weigang E; Scheld HH; Schmid C
    Ann Thorac Surg; 2007 May; 83(5):1697-705. PubMed ID: 17462383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension.
    Lim HS; Howell N; Ranasinghe A
    Int J Artif Organs; 2017 Mar; 40(2):67-73. PubMed ID: 28315502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Banding the Right Ventricular Assist Device Outflow Conduit: Is It Really Necessary With Current Devices?
    Lo C; Gregory S; Stevens M; Murphy D; Marasco S
    Artif Organs; 2015 Dec; 39(12):1055-61. PubMed ID: 25994563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.
    Han J; Takeda K; Takayama H; Kurlansky PA; Mauro CM; Colombo PC; Yuzefpolskaya M; Fukuhara S; Truby LK; Topkara VK; Garan AR; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):520-7.e1. PubMed ID: 26806510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
    Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
    J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.
    Neuss M; Schau T; Isotani A; Pilz M; Schöpp M; Butter C
    JACC Cardiovasc Interv; 2017 May; 10(9):931-939. PubMed ID: 28473116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary Hypertension After Heart Transplantation in Patients Bridged with the Total Artificial Heart.
    Shah R; Patel DB; Mankad AK; Rennyson SL; Tang DG; Quader MA; Smallfield MC; Kasirajan V; Shah KB
    ASAIO J; 2016; 62(1):69-73. PubMed ID: 26479463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.